DCAF7 Antibody

Code CSB-PA026056ESR2HU
Size US$166
Order now
Image
  • Immunohistochemistry of paraffin-embedded human colon cancer using CSB-PA026056ESR2HU at dilution of 1:100

Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) DCAF7 Polyclonal antibody
Uniprot No.
Target Names
DCAF7
Alternative Names
AN11 antibody; Dcaf7 antibody; DCAF7_HUMAN antibody; DDB1- and CUL4-associated factor 7 antibody; HAN11 antibody; Human anthocyanin antibody; Petunia antibody; Seven WD repeat protein of the AN11 family 1 antibody; SWAN 1 antibody; WD repeat domain 68 antibody; WD repeat protein An11 homolog antibody; WD repeat-containing protein 68 antibody; WD repeat-containing protein An11 homolog antibody; WDR68 antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human DDB1- and CUL4-associated factor 7 protein (1-342AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Polyclonal
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Form
Liquid
Tested Applications
ELISA, IHC
Recommended Dilution
Application Recommended Dilution
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Involved in craniofacial development. Acts upstream of the EDN1 pathway and is required for formation of the upper jaw equivalent, the palatoquadrate. The activity required for EDN1 pathway function differs between the first and second arches. Associates with DIAPH1 and controls GLI1 transcriptional activity. Could be involved in normal and disease skin development. May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex.
Gene References into Functions
  1. Immunoprecipitation and pulldown experiments identified DCAF7 as an adaptor for the association of the adenovirus E1A protein with DYRK1A and HIPK2 PMID: 27307198
  2. knockdown of DCAF7 reduced the degradation of DNA ligase I in response to inhibition of proliferation and replacement of ubiquitylated lysine residues reduced the in vitro ubiquitylation of DNA ligase I by Cul4-DDB1 and DCAF7. In contrast, a different E3 ubiquitin ligase regulates FEN-1 turnover. PMID: 27573245
  3. results demonstrate that the molecular chaperone TRiC/CCT is essential for correct protein folding, DYRK1A binding, and nuclear accumulation of WDR68. PMID: 25342745
  4. DYRK1A binds specifically to WDR68 in cells; the binding, but not the phosphorylation event, induces the nuclear translocation of WDR68. PMID: 21777625
  5. Han11 was required to allow coupling of MEKK1 to DYRK1 and HIPK2. PMID: 20940704
  6. that AN11 may be a physiological regulator of GLI1 transcriptional activity PMID: 16887337

Show More

Hide All

Subcellular Location
Cytoplasm. Nucleus. Note=Overexpression of DIAHP1 or active RHOA causes translocation from the nucleus to cytoplasm.
Protein Families
WD repeat DCAF7 family
Database Links

HGNC: 30915

OMIM: 605973

KEGG: hsa:10238

STRING: 9606.ENSP00000308344

UniGene: Hs.410596

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*